Alector, Inc. (ALEC) is a biological products, (no diagnostic substances) company, listed on the Nasdaq. With a market capitalization of $265 million, Alector, Inc. is a micro-cap company. The stock currently trades at $2.21, down 9.05% today, with a 52-week range of $0.87–$3.40.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.39 | $-1.39 | -13.0% | |
| 2024 | $-1.23 | $-1.23 | +21.2% | |
| 2023 | $-1.56 | $-1.56 | +3.7% | |
| 2022 | $-1.62 | $-1.62 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-25 | 0001193125-26-071593 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0000950170-25-027758 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0000950170-24-021183 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0000950170-23-005111 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0000950170-22-001979 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001564590-21-008860 | SEC ↗ |
| 2019-12-31 | 2020-03-24 | 0001564590-20-012520 | SEC ↗ |
| 2018-12-31 | 2019-03-26 | 0001564590-19-009358 | SEC ↗ |